EuroMOMO Bulletin, Week 1, 2021
Substantial increased excess mortality seen in Europe
The weekly pooled EuroMOMO estimates through December, show a substantial increased excess all-cause mortality overall for the participating European countries, coinciding with a reported increase in COVID-19 cases in several countries over the same period.
This excess mortality was driven by a very substantial excess mortality in some countries, while other countries see normal mortality levels.
The increased excess all-cause mortality is primarily seen among persons aged 45 years and older.
Data from 27 European countries or regions were included in this week’s pooled analysis of all-cause mortality.
Note on interpretation of data: The number of deaths shown for the three most recent weeks should be interpreted with caution, as adjustments for delayed registrations may be imprecise. Furthermore, results of pooled analyses may vary depending on countries included in the weekly analyses. Pooled analyses are adjusted for variation between the included countries and for differences in the local delay in reporting
About EuroMOMO network data sharing and collaboration
During the current COVID-19 pandemic, information on its mortality impact is of major concern. The EuroMOMO network hub receives many questions about the weekly mortality data we present, as well as requests to share the underlying national data. While the network fully supports data sharing, the network hub is not mandated by the participating countries to release any national data. If you are interested in accessing national data, please approach countries individually.
The EuroMOMO network welcomes collaboration with external partners, e.g. about additional analyses and modelling to be performed. If you are interested in engaging with the network about any such collaboration, please forward your ideas to the hub, for wider sharing and dialogue with the network.
Kindly note that any use of data or information originating from the EuroMOMO website must be appropriately quoted and acknowledged.